Zürich Area, Switzerland
Associate Director, QA at UCB
Biotechnology
Education
Vrije Universiteit Brussel 1986 — 1996
Ph.D., Applied Biol. Sciences - Spec. Biochemistry, Summa cum laude
Vrije Universiteit Brussel 1980 — 1985
MS Engineering, Chemistry - Spec. Biotechnology, Cum laude
Koninklijk Atheneum Koekelberg 1974 — 1980
High School, Latin-Mathematics
Experience
UCB December 2014 - Present
Agilent Technologies June 2014 - November 2014
ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company June 2012 - June 2013
ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company January 2011 - June 2012
Lonza June 2009 - October 2010
ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company December 2006 - June 2009
Harvard Medical School - Brigham and Women's Hospital March 2006 - August 2006
Brown University Medical School - Women and Infants Hospital RI January 2003 - November 2005
Marine Biological Laboratory September 2000 - December 2002
Harvard Medical School - Beth Israel Deaconess Med. Center June 1996 - August 2000
Skills
Protein Purification, Analytical Chemistry, FDA, Lifesciences, IND, 21 CFR Part 11, LIMS, CAPA, Immunology, Fermentation, Monoclonal Antibodies, SDS-PAGE, USP, Protein Chemistry, Biochemistry, Biopharmaceuticals, HPLC, Validation, Sop, PCR, Regulatory Requirements, V&V, Cell, Trackwise, Change Control, Immunoassays, Microbiology, Technology Transfer, Chromatography, Aseptic Processing, Regulatory Affairs, Purification, Assay Development, ELISA, Cell Culture, GLP, Pharmaceutical Industry, Quality Control, qPCR, Laboratory, Vaccines, GxP, GMP, Drug Discovery, Aseptic Technique, Biotechnology, Computer System..., Cleaning Validation, Molecular Biology, Regulatory Submissions